{
  "id": 9026024,
  "title": "BridgeBio Pharma CEO Neil Kumar sells $690,847 in shares",
  "url": "https://urgent.news/2026/09/21/bridgebio-pharma-ceo-neil-kumar-sells-690-847-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-21T22:46:13.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/bridgebio-pharma-ceo-neil-kumar-sells-690847-in-shares-93CH-4909733"
  },
  "original_language": "en",
  "account": "BridgeBio Pharma CEO Neil Kumar offloaded a total of 10,000 shares of the company's common stock on September 17, 2026, through a pre-approved Rule 10b5-1 sales plan. The transactions were carried out between May 13, 2026, and September 17, 2026, and generated $690,847 in proceeds. The shares were sold within the range of $69.0136 to $69.5696 per share, with an 8,721 share allocation at an average price of $69.0136 and 1,279 shares at an average price of $69.5696. Kumar, who holds a majority indirect beneficial ownership in the company, also maintains a significant stake through various trusts and a granting-related trust (GRAT). Despite recent stock performance indicating slight overvaluation, major brokerage firms such as Canaccord and H.C. Wainwright have maintained a Buy rating for BridgeBio Pharma, supporting its potential for growth.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": "https://urgent.news/ill/9026024.png",
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Telos chairman & CEO John Wood sells $389,411 in shares",
        "url": "https://urgent.news/2026/09/21/telos-chairman-ceo-john-wood-sells-389-411-in-shares",
        "published": "2026-09-21T23:31:12.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}